Jagat Pharma launches Isotine Eye gummies for vision support

These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development

Venturing into the nutraceutical segment, Jagat Pharma, a leading Ayurvedic wellness company renowned for its effective Ayurvedic products, particularly in eye health, has announced the launch of Isotine Eye Gummies. These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development.

Isotine Eye Gummies come in two specific formulations: one for children and one for adults (18+ years). These gummies enhance vision by blending essential nutrients and antioxidants carefully formulated to support eye health. Contents like Vitamin C and Vitamin E act as potent antioxidants, shielding the eyes from oxidative stress and promoting overall eye function. Lutein and Zeaxanthin, naturally occurring carotenoids in the retina, help filter harmful blue light and support macular health, crucial for maintaining sharp central vision. Astaxanthin further bolsters these benefits by reducing inflammation and enhancing blood flow to the retina. Together, these ingredients protect against digital eye strain caused by prolonged screen time and nourish eye tissues, promoting clearer vision and reducing discomfort associated with excessive screen exposure.

Jagat Pharma’s commitment to quality and natural ingredients is evident in the formulation of Isotine Eye Gummies. The gummies are made with Corn Syrup, Sugar, Water, Gelling Agents, Natural Flavors (Strawberry Mix), Black Carrot Concentrate, and Stevia, ensuring a delightful taste while adhering to the highest safety and efficacy standards. As dietary supplements, Isotine Eye Gummies are intended to support eye health and should not replace professional medical advice or treatment.

Read Previous

India’s pulse production increase to 244.93 lakh tonnes

Read Next

Cooking device On2Cook expands global footprint with patents in Russiaย 

Leave a Reply